Cancer Information

VIDEOS

ASCO Lung Cancer Roundtable - NSCLC Trial Updates: Checkmate 227 Opdivo Yervoy Combination Today

We are happy to present more videos for the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual...

ASCO Lung Cancer Roundtable - NSCLC - New Potential Treatments for MET and RET Positive NSCLC

We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with Helena...

ASCO Lung Cancer Roundtable - NSCLC - Enhertu and the Potential for Treatment of HER2 Positive NSCLC

We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with Helena...

ASCO Lung Cancer Roundtable - NSCLC - The SINDAS Trial: Addition of SBRT to a Systemic TKI for EGFR

We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with Helena...

ASCO Lung Cancer Roundtable - NSCLC - The CITYSCAPE Trial: Anti TIGIT & Immune Checkpoint Inhibitor

We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with Helena...

ARTICLES

Sexual Health During Cancer Treatment

Sex is that one word that can mean and feel so different depending on the context of our lives. As young teenagers, the word may fill us with a sense...

GRACE Programs and Annual Report
Únase a GRACE para el Foro de pacientes de terapias dirigidas 2021, presentado en español

2021 EN VIVO ONLINE Foro Español de Pacientes de Terapias Dirigidas 22 de julio de 2021 6:30 - 8:00 PM hora del este ¡Regístrate ahora! ¡La...

GRACE 990 2020
2021 Patient Education Ambassadors Program

Applications are now open! 2021 Patient Education Ambassadors Program Online Information Form and Application available here! GRACE Patient Education...

ONLINE COMMUNITY

Spanish Language Targeted Therapies Forum, Live, Online, and Free

Grace's 2nd Annual Spanish-Language Targeted Therapies Forum is coming up on Saturday, July 30! We are very excited to host this virtual event in...

Watch Videos of 7/16/22 Targeted Therapies Live Forum

Our Targeted Therapies Forum was Saturday 7/16/2022. The forum was/is packed full of excellent, understandable, and useful information from our...

Squamous NSCLC with Mutation

I was dx Stage 4 squamous NSCLC with MET amplification mutation. I have been looking for 3 years for others that have squamous with any mutation. I'm...

6 mm ground glass nodule

Hello all! I am new to this forum, and although I have not been diagnosed with cancer, I did discover on a relatively recent CT scan that I have a 6mm...

Transition from Tarceva to Tagrisso Chemotherapy

Hi everyone, my father has been diagnosed with Stage IV NSCLC in 2013 with metastasis to the pelvic region. The biopsy at the time revealed tumor...

Recent Comments

A question regarding treating plan of SCLC
Maeve, Hello
Comment By JanineT GRACE … on Jan 7, 2025 10:10 am
Multiple EGFR mutation lung cancer
Tagrisso is the latest drug…
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
Multiple EGFR mutation lung cancer
4th generation of EGFR
Comment By JanineT GRACE … on Aug 13, 2025 9:22 am
IMA (BAC) recurrence 21 years and 24 years out
(At least for the carnivores…
Comment By JanineT GRACE … on May 21, 2024 11:20 am

Targeted Therapies Patient Forum in Boston

Discussion Topic
General Lung/Thoracic Cancer

 MARCH 28, PUT IN ON YOUR CALENDARS.

I always learn so much at the live patient forums even attending them virtually.  

 

Our faculty is outstanding in their field not only because of their work in groundbreaking research and exceptional patient care they are also leaders in the field of Shared Decision Making or SDM.  We're lucky to have this opportunity to learn from and ask questions of these oncologists and patient advocates. 

 

I hope to see you in Boston, well for me to share this experience virtually,

 

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.

Case Based Panel Discussion - Stage 3 NSCLC - Immunotherapy Combos Checkmate 227 a Treatment Option?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

 Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion Stage 3 NSCLC - Tumor Mutational Burden (TMB), and the Value in Testing

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC. 

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Stage 3 NSCLC Patient with PDL1 Score of 0, Is Immunotherapy Beneficial?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Stage 3 NSCLC Treatment Standard and the Risk of Potential Pneumonitis

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion Stage 3 NSCLC - Does Timing of Treatment Make a Difference in Response

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Unresectable NSCLC, In a Frail Patient with Competing Risks, Is the Standard Treatment the Best Approach?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC .   

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Afatinib after Tarceva EGFR Exon18

Discussion Topic
Stage IV NSCLC

Hope somebody can help me.

Mum diagnosed with stage iv NSCLC in May of last year with spinal meta. Oncologist said she was a prime candidate for pembrolizumab. After 5 treatments oncologist said it didn't work as primary tumour had grown. 
oncologist the said that Mum had EGFR Exon18 and that Tarceva would be best option. After 3 months on tarceva Mum now has small mets on brain x 3 and two on liver. Oncologist now says that chemo only option.

Subscribe to In Treatment